Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 184

1.

Effects of hyperglycemia on lonidamine-induced acidification and de-energization of human melanoma xenografts and sensitization to melphalan.

Nath K, Nelson DS, Heitjan DF, Zhou R, Leeper DB, Glickson JD.

NMR Biomed. 2015 Mar;28(3):395-403. doi: 10.1002/nbm.3260.

PMID:
25702942
2.

Lonidamine induces intracellular tumor acidification and ATP depletion in breast, prostate and ovarian cancer xenografts and potentiates response to doxorubicin.

Nath K, Nelson DS, Heitjan DF, Leeper DB, Zhou R, Glickson JD.

NMR Biomed. 2015 Mar;28(3):281-90. doi: 10.1002/nbm.3240. Epub 2014 Dec 12.

PMID:
25504852
3.

The aspartate metabolism pathway is differentiable in human hepatocellular carcinoma: transcriptomics and (13) C-isotope based metabolomics.

Darpolor MM, Basu SS, Worth A, Nelson DS, Clarke-Katzenberg RH, Glickson JD, Kaplan DE, Blair IA.

NMR Biomed. 2014 Apr;27(4):381-9. doi: 10.1002/nbm.3072. Epub 2014 Feb 4.

4.

Is higher lactate an indicator of tumor metastatic risk? A pilot MRS study using hyperpolarized (13)C-pyruvate.

Xu HN, Kadlececk S, Profka H, Glickson JD, Rizi R, Li LZ.

Acad Radiol. 2014 Feb;21(2):223-31. doi: 10.1016/j.acra.2013.11.014.

5.

Noninvasive phosphorus magnetic resonance spectroscopic imaging predicts outcome to first-line chemotherapy in newly diagnosed patients with diffuse large B-cell lymphoma.

Arias-Mendoza F, Payne GS, Zakian K, Stubbs M, O'Connor OA, Mojahed H, Smith MR, Schwarz AJ, Shukla-Dave A, Howe F, Poptani H, Lee SC, Pettengel R, Schuster SJ, Cunningham D, Heerschap A, Glickson JD, Griffiths JR, Koutcher JA, Leach MO, Brown TR.

Acad Radiol. 2013 Sep;20(9):1122-9. doi: 10.1016/j.acra.2013.04.013.

6.

Mapping the redox state of CHOP-treated non-Hodgkin's lymphoma xenografts in mice.

Xu HN, Mir TA, Lee SC, Feng M, Farhad N, Choe R, Glickson JD, Li LZ.

Adv Exp Med Biol. 2013;789:243-9. doi: 10.1007/978-1-4614-7411-1_33.

PMID:
23852501
7.

CHOP THERAPY INDUCED MITOCHONDRIAL REDOX STATE ALTERATION IN NON-HODGKIN'S LYMPHOMA XENOGRAFTS.

Xu HN, Zhao H, Mir TA, Lee SC, Feng M, Choe R, Glickson JD, Li LZ.

J Innov Opt Health Sci. 2013 Apr;6(2):1350011.

8.

Impact of transvascular and cellular-interstitial water exchange on dynamic contrast-enhanced magnetic resonance imaging estimates of blood to tissue transfer constant and blood plasma volume.

Paudyal R, Poptani H, Cai K, Zhou R, Glickson JD.

J Magn Reson Imaging. 2013 Feb;37(2):435-44. doi: 10.1002/jmri.23837. Epub 2012 Nov 29.

PMID:
23197427
9.

Human Hepatocellular Carcinoma Metabolism: Imaging by Hyperpolarized 13C Magnetic Resonance Spectroscopy.

Darpolor MM, Kaplan DE, Pedersen PL, Glickson JD.

J Liver Disease Transplant. 2012 Sep 1;1(1). doi: 10.4172/2325-9612.1000101.

10.

Metabolic network analysis of DB1 melanoma cells: how much energy is derived from aerobic glycolysis?

Shestov AA, Mancuso A, Leeper DB, Glickson JD.

Adv Exp Med Biol. 2013;765:265-71. doi: 10.1007/978-1-4614-4989-8_37.

PMID:
22879043
11.

Lactate detection in inducible and orthotopic Her2/neu mammary gland tumours in mouse models.

Magnitsky S, Belka GK, Sterner C, Pickup S, Chodosh LA, Glickson JD.

NMR Biomed. 2013 Jan;26(1):35-42. doi: 10.1002/nbm.2816. Epub 2012 Jul 5.

12.

(31) P and (1) H MRS of DB-1 melanoma xenografts: lonidamine selectively decreases tumor intracellular pH and energy status and sensitizes tumors to melphalan.

Nath K, Nelson DS, Ho AM, Lee SC, Darpolor MM, Pickup S, Zhou R, Heitjan DF, Leeper DB, Glickson JD.

NMR Biomed. 2013 Jan;26(1):98-105. doi: 10.1002/nbm.2824. Epub 2012 Jun 29.

13.

Prediction and Early Detection of Response by NMR Spectroscopy and Imaging.

Lee SC, Arias-Mendoza F, Poptani H, Delikatny EJ, Wasik M, Marzec M, Schuster SJ, Nasta SD, Svoboda J, O'Connor OA, Smith MR, Glickson JD.

PET Clin. 2012 Jan;7(1):119-126. No abstract available.

14.

Decreased lactate concentration and glycolytic enzyme expression reflect inhibition of mTOR signal transduction pathway in B-cell lymphoma.

Lee SC, Marzec M, Liu X, Wehrli S, Kantekure K, Ragunath PN, Nelson DS, Delikatny EJ, Glickson JD, Wasik MA.

NMR Biomed. 2013 Jan;26(1):106-14. doi: 10.1002/nbm.2825. Epub 2012 Jun 18.

15.

Evaluation of bacteriochlorophyll-reconstituted low-density lipoprotein nanoparticles for photodynamic therapy efficacy in vivo.

Marotta DE, Cao W, Wileyto EP, Li H, Corbin I, Rickter E, Glickson JD, Chance B, Zheng G, Busch TM.

Nanomedicine (Lond). 2011 Apr;6(3):475-87. doi: 10.2217/nnm.11.8.

16.

In vivo and ex vivo MR imaging of slowly cycling melanoma cells.

Magnitsky S, Roesch A, Herlyn M, Glickson JD.

Magn Reson Med. 2011 Nov;66(5):1362-73. doi: 10.1002/mrm.22917. Epub 2011 Apr 26.

17.

NMR metabolic and physiological markers of therapeutic response.

Lee SC, Poptani H, Delikatny EJ, Pickup S, Nelson DS, Schuster SJ, Nasta SD, Svoboda J, Goldstein SC, Wallace SG, Loevner LA, Mellon EA, Reddy R, Glickson JD.

Adv Exp Med Biol. 2011;701:129-35. doi: 10.1007/978-1-4419-7756-4_18.

PMID:
21445779
18.

³¹P-MRS studies of melanoma xenografts with different metastatic potential.

Li LZ, Zhou R, Leeper DB, Glickson JD.

Adv Exp Med Biol. 2011;701:69-73. doi: 10.1007/978-1-4419-7756-4_10.

PMID:
21445771
19.

Early detection of radiation therapy response in non-Hodgkin's lymphoma xenografts by in vivo 1H magnetic resonance spectroscopy and imaging.

Lee SC, Poptani H, Pickup S, Jenkins WT, Kim S, Koch CJ, Delikatny EJ, Glickson JD.

NMR Biomed. 2010 Jul;23(6):624-32. doi: 10.1002/nbm.1505.

PMID:
20661875
20.

Quantitative mitochondrial redox imaging of breast cancer metastatic potential.

Xu HN, Nioka S, Glickson JD, Chance B, Li LZ.

J Biomed Opt. 2010 May-Jun;15(3):036010. doi: 10.1117/1.3431714.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk